✦ LIBER ✦
8029 POSTER Health-Related Quality of Life (HRQoL)/Patient Reported Outcomes (PRO) of Patients (pts) With Partially Platinum Sensitive (PPS) Recurrent Ovarian Cancer (ROC) Treated in a Randomized Phase III Trial of Trabectedin and Pegylated Liposomal Doxorubicin (PLD) Vs PLD Alone (OVA-301) – an Exploratory Analysis
✍ Scribed by Verqote, I.; Bidzinski, M.; Kelley, J.; Vasanthan, S.; Runnebaum, I.; Vermorken, J.; Arranz, J.A.; Almorin, E.; Park, Y.; Lisyanskaya, A.
- Book ID
- 123364177
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 45 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.